Lux Capital Hires Karen Eliadis as Chief Financial Officer

  Lux Capital Hires Karen Eliadis as Chief Financial Officer

Veteran Venture Capital CFO Joins Lux in Palo Alto office

Business Wire

PALO ALTO, Calif. -- June 25, 2013

Lux Capital, a leading venture capital firm, today announced that Karen
Eliadis has joined the firm as its Chief Financial Officer (CFO) based in Palo
Alto.

Karen Eliadis, CFO, Lux Capital (Photo: Business Wire)

Karen Eliadis, CFO, Lux Capital (Photo: Business Wire)

Karen was most recently the Chief Financial Officer of BlueRun Ventures, a
global venture capital firm with more than $1 billion in assets, based in
Menlo Park. She was previously Director of Finance of Sofinnova Ventures, a
Menlo Park-based technology and life science venture capital firm. Before
joining Sofinnova, Karen was Managing Director, Finance for a private equity
firm and held senior finance positions at several large organizations. She is
a CPA and began her career at Deloitte. Karen is actively involved in the
venture community, leading as chair and board member of VCBC, a 250+ member
organization of finance professionals in venture capital, and serving on
several committees of the NVCA CFO Task Force. In July, Karen will join the
board of the West Coast Chapter of the Private Equity CFO Association.

“We’re proud to add Karen to the Lux team,” said Peter Hebert, Co-founder and
Managing Partner of Lux Capital. “She’s established herself as a leader in the
venture capital finance community and her acumen and insights will be integral
to Lux’s continued expansion.”

"Having been intimately involved in the venture industry for more than a
decade, I have great admiration for the unique franchise Lux Capital has
built,” said Eliadis.“I’m very excited to join at an obvious inflection point
in the firm’s growth.”

About Lux Capital

Lux Capital is a leading venture firm focused on founding, seed and early
stage investments in emerging technologies. Lux takes an active role in
helping entrepreneurs build successful businesses in Energy, Life Sciences and
Technology. The Lux investment team has founded more than 20 companies from
scratch, including Caliper, Genocea, Illumina, Kala, Kurion, Lux Research,
Nanosys, Neurocrine Biosciences, and Vertex Pharmaceuticals. For more
information please visitwww.luxcapital.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130625005086/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50658022&lang=en

Contact:

Lux Capital
Bibi Masara, 646-723-2217
bibi.masara@luxcapital.com